Showing results (131-140 of 286) with videos related to

Sort By:
Pageof 29
Organic & Biomolecular Chemistry|January 24, 2022
Reaction-based fluorescence probes for "turn on" sensing fluoride ionsWen-Ying He, Ning Liu, Xu Jiang, et al.
Journal of Zhejiang University. Science|May 27, 2003
Polymorphisms in the genes for coagulation factor II, V, VII in patients undergoing coronary angiographyXu Geng, Guo-Dong Jin, Guo-Sheng Fu, et al.
Chinese Medical Journal|October 23, 2003
Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failureYingxin Peng, Jiang Shan, Xiaoyong Qi, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
A comparison of the changes in serum lactate between surgical repair and transthoracic device closure of ventricular septal defects in pediatric patientsJiang-Shan Huang, Yu-Kun Chen, Shi-Hao Lin, et al.
Journal of Cardiothoracic Surgery|April 10, 2019
Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patientsJiang-Shan Huang, Qiang Chen, Liang-Wan Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Association of the MspI polymorphism of cytochrome P4501A1 gene and smoking to the susceptibility to coronary artery disease]Xiao-ming Zhang, Geng Xu, Jiang Shan, et al.
Frontiers in Plant Science|July 25, 2022
Distribution Pattern of N6-Methyladenine DNA Modification in the Seashore Paspalum (<i>Paspalum vaginatum</i>) GenomeJiang-Shan Hao, Jian-Feng Xing, Xu Hu, et al.
Frontiers in Immunology|May 18, 2026
Mechanical cues as immunomodulators in neuroinflammation-driven spinal sensitization: analgesic mechanisms and therapeutic strategiesLi-Ya Tang, Ke-Shang Li, Xiao-Xia Kuang, et al.
Chinese Medical Journal|April 12, 2017
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective StudyJing Zhou, Yue-Ying Liu, Jiang-Shan Lian, et al.
British Journal of Pharmacology|December 9, 2025
The sodium-glucose co-transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor-βTing-Ting Lyu, Jing-Yang Wang, Jiang-Shan Tan, et al.
Pageof 29